Abbott Glenn L, Blouse Grant E, Perron Michel J, Shore Joseph D, Luck Linda A, Szabo Arthur G
Department of Chemistry, University of Waterloo, Ontario, Canada.
Biochemistry. 2004 Feb 17;43(6):1507-19. doi: 10.1021/bi035618a.
Plasminogen activator inhibitor-1 (PAI-1) is a 43 kDa protein involved in the regulation of fibrinolysis. PAI-1 is the principal inhibitor of tissue-type plasminogen activator (t-PA), trapping the proteinase as an acyl-enzyme covalent complex (approximately 105 kDa). Four single tryptophan mutants of PAI-1 have been constructed in which three of the four tryptophan residues (Trp86, Trp139, Trp175, and Trp262) were replaced with phenylalanine. Biosynthetic incorporation of 5-fluorotryptophan (5F-Trp) into wild-type PAI-1 (5FW wtPAI-1) and the single tryptophan mutants (5FW86, 5FW139, 5FW175, and 5FW262) was achieved, allowing a (19)F NMR spectroscopic study of PAI-1 in its active and cleaved forms and in complex with t-PA. The (19)F NMR spectrum of active 5FW wtPAI-1 shows four clearly resolved peaks at -39.20, -49.26, -50.74, and -52.57 ppm relative to trifluoroacetic acid at 0 ppm. Unequivocal assignments of these four resonances in the spectrum of 5FW wtPAI-1 to specific tryptophan residues were accomplished by measuring the chemical shifts of the (19)F resonances of the single tryptophan mutants. There was close agreement between the resonances observed in 5FW wtPAI-1 and of those in the mutants for all three protein forms. This would imply little structural perturbation in the local structures of the tryptophan residues resulting from substitution by phenylalanine. The 5FW wtPAI-1 was observed to have lower second-order rate constant (k(app)) for the inhibition of t-PA than the natural tryptophan wtPAI-1, suggesting that the decreased activity may result from a small structural effect of the fluorine substituent of the indole ring. Further alterations in the k(app) and the stoichiometry of inhibition (SI) were observed in each of the mutants indicating an effect of the three tryptophan to phenylalanine mutations. Detailed interpretation of the (19)F NMR spectra of the PAI-1 mutants provides insights into the local segmental structure of the active form of the proteins and the structural changes that occur in the cleaved and t-PA complexed forms.
纤溶酶原激活物抑制剂-1(PAI-1)是一种43 kDa的蛋白质,参与纤维蛋白溶解的调节。PAI-1是组织型纤溶酶原激活物(t-PA)的主要抑制剂,它将蛋白酶捕获为酰基酶共价复合物(约105 kDa)。已构建了PAI-1的四个单色氨酸突变体,其中四个色氨酸残基(Trp86、Trp139、Trp175和Trp262)中的三个被苯丙氨酸取代。实现了将5-氟色氨酸(5F-Trp)生物合成掺入野生型PAI-1(5FW wtPAI-1)和单色氨酸突变体(5FW86、5FW139、5FW175和5FW262)中,从而能够对PAI-1的活性形式、裂解形式以及与t-PA形成的复合物进行(19)F核磁共振光谱研究。活性5FW wtPAI-1的(19)F核磁共振谱显示,相对于0 ppm处的三氟乙酸,在-39.20、-49.26、-50.74和-52.57 ppm处有四个清晰分辨的峰。通过测量单色氨酸突变体的(19)F共振的化学位移,明确了5FW wtPAI-1谱中这四个共振峰与特定色氨酸残基的对应关系。对于所有三种蛋白质形式,在5FW wtPAI-1中观察到的共振与突变体中的共振之间有密切的一致性。这意味着苯丙氨酸取代导致色氨酸残基的局部结构几乎没有结构扰动。观察到5FW wtPAI-1对t-PA的抑制作用比天然色氨酸wtPAI-1具有更低的二级速率常数(k(app)),这表明活性降低可能是由于吲哚环氟取代基的微小结构效应所致。在每个突变体中还观察到k(app)和抑制化学计量比(SI)的进一步变化,表明三个色氨酸到苯丙氨酸的突变产生了影响。对PAI-1突变体的(19)F核磁共振谱的详细解释为蛋白质活性形式的局部片段结构以及裂解形式和与t-PA形成复合物的形式中发生的结构变化提供了深入了解。